结合电刺激和声放大的Cochlear植入器
PMA编号：P130016 · 2026-04-30
广告
决定日期2026-04-30
PMA 编号P130016
产品代码PGQ
设备分类第3类
医疗专科U
咨询委员会医疗设备监管文本描述翻译如下：
关于[公司/产品名称]的监管信息：
- 美国食品药品监督管理局（FDA）批准号：[510(k)编号]
- 预市场批准（PMA）申请号：[PMA编号]
- 临床试验注册号（NCT）：[NCT编号]
- 医学文献标识符（PMID）：[PMID编号]
- 产品标识符：[标识符]
- 相关政策：医疗监管政策v1
- 更多信息请访问：[URL]
请注意，以上翻译保留了公司/产品名称、FDA、510(k)、PMA、NCT、PMID、标识符和URL。
器械摘要
Cochlear implant with combined electrical stimulation and acoustic amplification is the device name listed in this FDA 510(k) record. The listed applicant is Cochlear Americas. It received FDA 510(k) clearance on 2026-04-30. The device is classified under product code PGQ. It was reviewed by the EN advisory panel.
常见问题
What is the Cochlear implant with combined electrical stimulation and acoustic amplification?
Cochlear implant with combined electrical stimulation and acoustic amplification is a medical device that received FDA 510(k) clearance on 2026-04-30. The listed applicant is Cochlear Americas.
When did Cochlear implant with combined electrical stimulation and acoustic amplification receive FDA 510(k) clearance?
The clearance date for Cochlear implant with combined electrical stimulation and acoustic amplification can be found in the official FDA records.
Who is the listed applicant for Cochlear implant with combined electrical stimulation and acoustic amplification?
The FDA 510(k) record lists Cochlear Americas as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Cochlear implant with combined electrical stimulation and acoustic amplification?
The FDA product code for Cochlear implant with combined electrical stimulation and acoustic amplification is PGQ.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告